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Abstract
Background: Porcine IGF2 and the H19 genes are imprinted. The IGF2 is paternally expressed, while the H19 gene
is maternally expressed. Extensive studies in mice established a boundary model indicating that the H19
differentially methylated domain (DMD) controls, upon binding with the CTCF protein, reciprocal imprinting of the
IGF2 and the H19 genes. IGF2 transcription is tissue and development specific involving the use of 4 promoters. In
the liver of adult Large White boars IGF2 is expressed from both parental alleles, whereas in skeletal muscle and
kidney tissues we observed variable relaxation of IGF2 imprinting. We hypothesized that IGF2 expression from both
paternal alleles and relaxation of IGF2 imprinting is reflected in differences in DNA methylation patterns at the H19
DMD and IGF2 differentially methylated regions 1 and 2 (DMR1 and DMR2).
Results: Bisulfite sequencing analysis did not show any differences in DNA methylation at the three porcine CTCF
binding sites in the H19 DMD between liver, muscle and kidney tissues of adult pigs. A DNA methylation analysis
using methyl-sensitive restriction endonuclease SacII and ‘hot-stop’ PCR gave consistent results with those from the
bisulfite sequencing analysis. We found that porcine H19 DMD is distinctly differentially methylated, at least for the
region formally confirmed by two SNPs, in liver, skeletal muscle and kidney of foetal, newborn and adult pigs,
independent of the combined imprinting status of all IGF2 expressed transcripts. DNA methylation at CpG sites in
DMR1 of foetal liver was significantly lower than in the adult liver due to the presence of hypomethylated
molecules. An allele specific analysis was performed for IGF2 DMR2 using a SNP in the IGF2 3’-UTR. The maternal
IGF2 DMR2 of foetal and newborn liver revealed a higher DNA methylation content compared to the respective
paternal allele.
Conclusions: Our results indicate that the IGF2 imprinting status is transcript-specific. Biallelic IGF2 expression in
adult porcine liver and relaxation of IGF2 imprinting in porcine muscle were a common feature. These results were
consistent with the IGF2 promoter P1 usage in adult liver and IGF2 promoter P2, P3 and P4 usages in muscle. The
results showed further that bialellic IGF2 expression in liver and relaxation of imprinting in muscle and kidney were
not associated with DNA methylation variation at and around at least one CTCF binding site in H19 DMD. The
imprinting status in adult liver, muscle and kidney tissues were also not reflected in the methylation patterns of
IGF2 DMRs 1 and 2.
Background
Porcine insulin-like growth factor 2 (IGF2) and H19
genes are reciprocally imprinted in most tissues. In
mice, these two genes share common endodermal and
mesodermal enhancers and the mouse Igf2 gene is also
paternally expressed in most tissues whereas the H19
gene is maternally transcribed [1-3]. Mice lacking the
Igf2 gene weighed about 40% less than their litter mates
[4]. The H19 gene expresses a non-protein-coding RNA
and is located 88.1 kb downstream of IGF2 [5,6].
Recently, it was found that H19 transcripts can function
as microRNA precursors [7].
The pig INS-IGF2-H19 imprinting cluster is highly
homologous to the corresponding human gene cluster
and is thus a good model to study epigenetic
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mechanisms [5]. Recently, a quantitative trait nucleotide
(QTN) at position IGF2-intron3-3072 was identified and
various antisense transcripts originate from the paternal
allele demonstrating the complex transcription from this
gene [8,9].
An extensive number of studies have been conducted
to elucidate the epigenetic mechanisms of IGF2 and
H19 which are thought to be co-ordinately regulated,
both in terms of their expression patterns and their reci-
procal imprinting (for review see [3]). It was shown by
deletions in mice that a region of paternal-specific DNA
methylation (differentially methylated domain, DMD)
upstream of H19 is an epigenetic mark required for
imprinting of IGF2 and H19 [10,11]. Bell and Felsenfeld
[12] reported that activity of H19 DMD depends upon
the vertebrate eleven-zinc finger protein CTCF that
binds to this DMD and mediates the function of the
boundary/insulator element. They also found that
methylated CpG sites at the CTCF binding site abol-
ished binding in vitro. Based on this finding Bell and
Felsenfeld [12] developed a model explaining the reci-
procal imprinting. On the maternal allele the enhancer
downstream of H19 has no access to the IGF2 promo-
ters due to the boundary function of CTCF proteins
bound to the unmethylated DMD whereas the H19 gene
can still be transcribed. On the paternal allele DNA
methylation at the H19 DMD eradicates the boundary
function which leads to IGF2 gene transcription and
silencing of the H19 gene. These findings were made
simultaneously using transgenic mice and cell culture
and contributed to establish the boundary model [13].
More recently it was demonstrated that differentially
methylated regions in the mouse Igf2 and H19 genes
interact in an epigenetically regulated manner that parti-
tion maternal and paternal alleles into distinct loops.
The maternal allele H19 DMD interacts with Igf2 DMR1
allowing maternal H19 to be expressed while the pater-
nal H19 DMD interacts with Igf2 DMR2, allowing Igf2
to be expressed and leaves the H19 gene silent. This
model was named the chromatin loop model [14].
A DMD between -1.1 and -2.6 kb upstream of the
H19 transcription start site has also been found to regu-
late porcine reciprocal transcription of H19 and IGF2
via a CTCF protein that binds to the unmethylated
maternal allele (Figure 1). In the pig H19 DMD, three
CTCF-binding motifs in P1, P2 and P3 repeats were
identified by sequence homology to the human H19
DMD [5]. Relaxation of IGF2 imprinting was observed
in skeletal muscle of 4 month old pigs compared to
nearly complete monoallelic expression in prenatal ske-
letal muscle [8]. Wrzeska et al. [15] reported biallelic
IGF2 expression in adult porcine liver and brain and
monoallelic IGF2 expression in muscle and kidney tis-
sues of adult pigs. Recently, it was reported that IGF2
transcripts from promoter P1 are also biallelically
expressed in tissues of week-old pigs whereas in most
other tissues, including skeletal muscle and kidney, IGF2
was monoallelically expressed [16]. Biallelic expression
of Igf2/IGF2 has been reported for choroids plexus and
leptomeninges of the mouse as well as in postnatal and
normal adult human liver [1,17,18]. A recent report by
Wu et al. [19] confirmed biallelic IGF2 expression in
normal human liver and showed a medium-methylated
H19 DMD profile with a hypermethylated paternal and
a hypomethylated maternal allele.
In an ongoing study we investigated the combined
imprinting status of all IGF2 expressed transcripts in
liver, skeletal muscle and kidney tissues of adult boars.
We hypothesized that an alteration in IGF2 imprinting
status might be reflected in DNA methylation variations
at differentially methylated regions as suggested by the
boundary and chromatin loop models. To test this
hypothesis we studied the association between the IGF2
imprinting status in three different tissue samples of six
boars and their DNA methylation of H19 DMD, IGF2
DMR1 and DMR2 (Figure 1). Furthermore, we included
samples from two foetus and two newborn pigs in order
to examine IGF2 imprinting and DNA methylation at
these differentially methylated regions during develop-
ment. We were curious to see whether the imprinting
status of IGF2 in liver, skeletal muscle and kidney at dif-
ferent developmental stages is also reflected in the DNA
methylation patterns of H19 DMD and in particular at
CTCF binding sites as well as in IGF2 DMR1 and IGF2
DMR2.
Results
Imprinting status of IGF2
We used the SWC9 microsatellite marker with alleles
236 bp and 247 bp to investigate the combined imprint-
ing status of IGF2 gene expression in liver, skeletal mus-
cle and kidney (Figure 1). The SWC9 microsatellite is
located in the 3’ UTR of the IGF2 gene and its sequence
is common to all IGF2 transcripts originating from dif-
ferent promoter usages in a specific tissue and develop-
mental stages. We investigated two pig foetuses, two
newborn piglets and six boars that were heterozygous
for the SWC9 marker. All but one boar received the
SWC9 allele 247 bp from their fathers and the SWC9
236 bp allele from their mothers. We established a stan-
dard curve with a dilution series of DNA from alterna-
tive homozygous individuals for the SWC9 marker [20].
As a measure for the imprinting status we calculated
the log2 ratio of the SWC9 236 bp peak area to the
SWC9 247 bp peak area and calculated the correspond-
ing ratio of SWC9 236 bp allele to SWC9 247 bp based
on the standard curve (Figure 2B). In Table 1 the ratios
of allelic IGF2 expression for the different tissues and
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development stages are shown. This experiment showed
that the imprinting status of IGF2 changes from pater-
nal expression in the foetal liver to IGF2 expression
from both parental alleles in the adult liver. Paternal
IGF2 gene expression is mostly maintained in kidney tis-
sue during development. In muscle tissue a trend of
relaxation of imprinting during development is indi-
cated. The considerable variation of these ratios is
mostly explained by the small sample size and a few
samples that substantially deviate from the mean but
were nonetheless kept in the analysis. IGF2 imprinting
in liver, muscle and kidney of foetal, newborn and adult
pigs is visualized by the SWC9 microsatellite profiles in
Figure 2A.
The observed biallelic IGF2 expression in these adult
boars’ liver is in agreement with previous reports show-
ing biallelic expression of IGF2 in the livers of humans
and pigs [15-19]. RT-PCR analysis of adult liver cDNA
indicated that all 4 IGF2 promoters were used whereas
cDNA from muscle and kidney revealed very low level
of products after 40 PCR cycles for transcripts from
promoter P1 and high level of products for transcripts
from promoter P2, P3, and P4 (data not shown). This
result is in agreement with previous findings from
Amarger et al. and Li et al. [5,16], however, from pre-
vious Northern blot analysis it is known that promoter
P1 is predominantly used in adult pig liver and tran-
scripts from promoter P2, P3 and P4 were not detected.
The RT-PCR analysis of microsatellite SWC9 is a semi-
quantitative approach to investigate IGF2 imprinting sta-
tus and the results conclusively indicate that IGF2
imprinting is reversed similarly to biallelic expression in
adult liver and it is relaxed to different degrees in mus-
cle and kidney tissues during development.
Bisulfite sequencing analysis of H19 DMD
Bisulfite sequencing of porcine H19 DMD indicated that
the region was indeed differentially methylated from
about -1 kb to -3 kb from the start site of H19 exon 1
(AY044827.1). We sequenced bisulfite treated DNA from
four overlapping PCR fragments derived from adult liver,
skeletal muscle and kidney DNA and found distinct
hyper- and hypomethylated molecules in each of the four
fragments. This strongly suggests that H19 DMD
extended at least over this region (PCR primers
H19_DMD_1 to H19_DMD_4, Additional file 1 Table
S1). In the two PCR fragments spanned by PCR primer
pairs (H19_DMD_2 and H19_DMD_3) two SNPs
(AY044827.1:g.32530C>T and AY044827.1:g.32619G>A)
were identified and thus the parental alleles deduced
which confirmed the DMD. This result is in perfect
agreement with the boundary model which explains the
mechanism by which CTCF’s binding at the H19 DMD
mediates chromatin insulator function and thus main-
tains the reciprocal imprinting of the IGF2 and H19
genes. We have analysed DNA methylation and in parti-
cular CpG sites at the CTCF binding site in the P2 repeat
in liver, muscle and kidney tissues of foetal, newborn and
adult pigs [5]. In Figure 3 DNA methylation patterns of
the bisulfite sequencing analysis are shown as a ‘lollipop’
graphic. There is no apparent difference in DNA methy-
lation at these three CpG sites within the CTCF binding
site P2 between liver, skeletal muscle and kidney tissues
in all development stages. Furthermore, a bisulfite
sequencing analysis from 7 to 13 clones from each of the
three tissues liver, kidney and muscle of three adult boars
indicated hyper- and hypomethylatd CTCF binding sites
in P1 and P3 repeats. This result is consistent with a
medium-methylated H19 DMD profile, although we did
not find a DNA polymorphism to determine the parental
origin of these clones (data not shown). Sanger sequen-
cing of bisulfite treated DNA molecules is laborious and
only a relatively small number of molecules can be
sequenced. There may also be heteroduplex artifacts pre-
sent during PCR amplification of bisulfite treated DNA
molecules because the bacterial host’s mismatch repair
system can convert paternal and maternal alleles into sin-
gle hybrid sequences during cloning. To account for
these drawbacks we performed a DNA methylation ana-
lysis using SacII and nonradioactive ‘hot-stop’ PCR [21].
E1 E3E2 E4 E5 E6 E7 E8 E9
P1
E4b
P2 P3 P4
IGF2
DMR1 DMR2
QTN
P
H19
DMD
E1 E5
E
2,3,488.1 kb
SWC9
CTCF
binding sites
P1 P2P3
Figure 1 Schematic drawing of the IGF2 and H19 gene loci. IGF2 exons (E), promoters (P1 to P4 and P), differentially methylated regions
(DMR1 and 2), the H19 differentially methylated domain (DMD), the quantitative trait nucleotide (QTN) and the microsatellite SWC9 are
indicated. CTCF binding sites in P1, P2 and P3 repeats are indicated in the DMD.
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This assay discriminates between DNA methylation at
maternal and paternal derived alleles at the CTCF bind-
ing site in the P2 repeat.
DNA methylation analysis using methyl-sensitive
restriction endonuclease
In Figure 4 the assay of the DNA methylation analysis
using a methyl-sensitive restriction endonuclease is
shown. SacII recognizes the CTCF binding site in the
P2 repeat and does not cleave if one or both of the two
CpG sites are methylated, i.e. the amplified products
represent at least one methylated CpG at the binding
site. Paternal and maternal alleles are discriminated by a
restriction site for BstUI. This assay detects the ratio
between paternal and maternal CpG methylation at the
P2 repeat in H19 DMD. The proportions of unmethy-
lated CpG sites in the CTCF binding site in the P2
repeat are not accounted for by this method. In lane 1
an undigested 464 bp PCR product is shown that is 29
bp longer than the digested longer allele since there is a
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Figure 2 SWC9 microsatellite marker capillary profiles of cDNA from pig liver, skeletal muscle and kidney tissues and a standard curve
of a dilution series of the alternative alleles. A The 247 bp allele is paternally inherited and the size of the peak area for the maternal 236 bp
allele is indicative for the level of IGF2 imprinting relaxation. The cDNA profiles from adult liver tissues show a similarity to biallelic IGF2
expression while those of cDNA from adult skeletal muscle and kidney indicate relaxation of imprinting. B Standard curve of mixed DNA from
respective homozygote individuals with 11 different ratios (see also in the section methods).
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second BstUI restriction site located in the CTCF bind-
ing site. Lanes 2 and 3 show the 137 bp fragment from
foetal tissues indicating paternal hypermethylation and
maternal hypomethylation at the CTCF P2 binding site.
Also in newborn pig tissues (lanes 4 and 5, fragments of
137 bp) and in the tissues of adult pigs (lanes 6 and 7,
137 bp and 435 bp, the later having the alternative
paternal allele methylated) paternal hypermethylation
and maternal hypomethylation at this CTCF P2 binding
sites is suggested. In lane 8 a control result of a 1:1 mix
of DNA from respective homozygous CC and TT boars
for the AY044827.1:g.32530.C>T polymorphism is
shown. The results of this assay consistently indicate
paternal hypermethylation and maternal hypomethyla-
tion at this CTCF binding site in the H19 DMD in the
three tissues and for the three development stages.
Table 1 Imprinting status in different pig tissues and for
three development stages expressed as ratio of paternal
to maternal IGF2 gene expression
Tissue Ratio paternal to maternal gene expression
(± SD)
Adult liver (N = 6) 4.2 (± 6.2)
Newborn liver (N = 2) 21.3 (± 0.01)
Foetal liver (N = 2) Paternal expression
Adult muscle (N = 6) 9.2 (± 6.2)
Newborn muscle (N
= 2)
19.9 (± 6.0)
Foetal muscle (N = 2) Paternal expression (N = 1) and 14 (N = 1))
Adult kidney (N = 6) 22.9 (± 10.2)
Newborn kidney (N =
1)
34.0
Foetal kidney (N = 2) Paternal expression
{
CTCF binding site in P2SNP (A/G)
m
p
p
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m
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m
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Figure 3 Bisulfite sequencing analysis of the CTCF consensus binding site in the P2 repeat of H19 DMD. Filled circles are methylated and
open circles are unmethylated cytosines at CpG sites. Maternal and paternal origins are indicated by m and p, respectively. The position of the
CTCF binding site in the P2 repeat and of the SNP (AY044827.1:g.32619G>A) are given.
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Bisulfite sequencing analysis of IGF2 DMR1
DNA polymorphisms that allowed the deduction of the
parental origin of alleles in the IGF2 DMR1 were not
found. Nevertheless we used bisulfite sequencing to ana-
lyse a considerable number of clones to search for speci-
fic DNA methylation patterns both between the three
tissue samples and during development, which are sup-
posed to be associated with the IGF2 imprinting status.
We compared DNA from between 7 and 37 single
clones per tissue and developmental stage and could not
find any significant difference between DMR1 methyla-
tion in muscle and kidney tissues within foetal, newborn
and adult individuals (Wilcoxon two-sample test, two-
sided).
There was a significant difference in DNA methylation
at DMR1 CpG sites between 22 clones from the foetal
liver compared to that of 33 clones from the adult pig
liver (P < 0.01, Wilcoxon two-sample test, two-sided). A
suggestive difference in DNA methylation at DMR1 was
found between 22 clones from foetal liver tissues and 13
clones from livers of two newborn piglets (P = 0.06). A
closer inspection of the data showed a small fraction of
hypomethylated DMR1 clones in the foetal liver. This
result must be interpreted cautiously due to the small
sample number. DMR1 was hypermethylated with over
70% DNA methylation in all tissue samples except for
foetal liver and the foetal muscle, which had 66% (22
clones) and 68% (22 clones) DNA methylation, respec-
tively. Representative lollipop diagrams are given in Fig-
ure 5 for all tissues and the three developmental stages.
A
IGF2 H19DMD
Hot-stop_r
IRD700-M13_f
Hot-stop_f
SacII
BstUI BstUI
CTCF binding site
C/T
P2
464 bp
Liver
Muscle
Kidney
1 3 652 7 84
435 bp
137 bp
464 bp
B
1 3 652 7 84
464 bp 435 bp
137 bp
3 51 62 7 8
464 bp 435 bp
137 bp
Sizes of amplified and digested products
464 bp435 bp137 bp
Figure 4 Methylation-sensitive restriction endonuclease SacII
digest of genomic DNA, ‘hot-stop’ PCR and subsequent BstUI
digest to discriminate between the maternal and paternal
alleles. A Schematic representation of the DNA methylation analysis
using methyl-sensitive restriction endonuclease SacII and ‘hot-stop’
PCR in the H19 DMD containing the P2 repeat. The recognition site
of SacII, ‘hot-stop’ PCR primers and the BstUI recognition sites are
indicated. B Scanned agarose gel by infrared fluorescent detection.
Lane 1 is an undigested 464 bp product that is 29 bp longer than
the digested longer allele since there is a second BstUI restriction
site. Lanes 2 and 3 show 137 bp fragments from foetal DNA
indicating paternal hypermethylation and maternal hypomethylation
at the CTCF P2 binding site. Lanes 4 and 5 are the 137 bp DNA
fragments from newborn tissues and lanes 6 and 7 (137 bp and 435
bp fragments, the later having the alternative paternal allele
methylated) are amplified DNA fragments from adult tissues. Also in
lanes 6 and 7 paternal hypermethylation and maternal
hypomethylation of the CTCF P2 binding sites are demonstrated. In
lane 8 a control result of a 1:1 mix of DNA from respective
homozygous CC and TT individuals for the AY044827.1:g.32530.C>T
polymorphism is shown.
Liver
Muscle
Kidney
Foetal
Newborn
Adult
Foetal
Newborn
Adult
Foetal
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Adult
Figure 5 Bisulfite sequencing analysis of the IGF2 DMR1 in
porcine liver, muscle and kidney tissues. Filled circles are
methylated and open circles are unmethylated cytosins at CpG sites.
The clones are a random selection from all individuals and different
tissues. DMR1 is hypermethylated but hypomethylated clones in
foetal liver were also detected. The parental origin of the clones is
unknown due to the lack of an informative SNP.
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In summary, the DMR1 at the IGF2 locus was largely
hypermethylated with some indication of hypomethy-
lated DNA molecules in foetal liver.
Bisulfite sequencing analysis of IGF2 DMR2
We used the IGF2-exon9-612A>T SNP to determine the
parental origin of DMR2 molecules from the bisulfite
sequence analysis. In Figure 6 maternal and paternal
profiles of the DNA methylation at each of the 17 CpG
sites are shown for three tissues and three developmen-
tal stages. Overall results showed hypermethylation of
both parental DMR2 alleles. We focused on differences
in DNA methylation of the two parental alleles in three
tissues and during development. We found significantly
higher DNA methylation along the 17 CpG sites on the
maternal allele in foetal (14 maternal clones versus 11
paternal clones) and newborn liver (24 maternal clones
versus 23 paternal clones) compared to the paternal
allele (P < 0.05, Wilcoxon two-sample test, two-sided).
However, it should be emphasised that both alleles were
hypermethylated with 71% and 64% in foetal and 87%
and 82% in the newborn liver for the respective
maternal and the paternal alleles. There was a tendency
that the maternal allele was also more methylated in
foetal and newborn muscle and kidney tissues compared
to the paternal allele. No significant differences in DNA
methylation were observed between the parental alleles
in the adult tissues.
Discussion
Van Laere et al. [8] and Wrzeska et al. [15] showed
relaxation of imprinting in skeletal muscle tissues of 4
month old pigs and exclusive paternal IGF2 expression
in the tissues of adult pigs’ skeletal muscle, respectively.
It is important to point out that insufficient PCR cycles,
or template, may lead to the product arising from the
maternal allele to go undetected, especially in the mus-
cle and kidney, where relaxation of imprinting seems to
increase with aging (Figure 2). This might be a reason
for the conflicting data found by Van Laere et al. [8]
and Wrzeska et al. [15]. In a comprehensive study the
imprinting status of IGF2 and H19 were determined in
13 tissue samples of week-old piglets [16]. Li et al.
(2008) [16] found biallelic IGF2 expression from
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Figure 6 The mean percentage of DNA methylation at each CpG site of maternal and paternal IGF2 DMR2 clones are shown for liver,
muscle and kidney and three development stages foetal, newborn and adult. Profiles were similar for both parental alleles and the three
different tissue samples. For most of the CpG sites a moderate hypermethylation was found. A minor higher DNA methylation content was
observed on the maternal allele in the foetal and newborn liver as compared to the paternal allele. The IGF2-exon9-612A>T SNP is located
downstream of the 17th CpG site and not indicated.
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promoter P1 in heart, liver, brain, lung, kidney, stomach,
pancreas, thymus, tongue, muscle, bladder, spleen, and
placenta tissues of week-old pigs. Their RT-PCR analysis
of microsatellite SWC9 in these 13 different tissues
revealed, however, exclusive or nearly exclusive paternal
IGF2 expression. Furthermore, their real-time PCR ana-
lysis of IGF2 exon 2 originating from promoter P1 and
of IGF2 exon 9, that is common for all IGF2 transcripts,
resulted in roughly 33% and 10% promoter P1 IGF2
transcription relative to total IGF2 transcription in brain
and placenta, respectively. These results are in agree-
ment with the data presented for IGF2 imprinting in
liver and suggest that transcription from the IGF2 pro-
moter P1 may be regulated by other mechanisms than
that from promoters P2, P3 and P4. Together these data
emphasize the promoter-specific IGF2 imprinting status
in different tissues and during development [16]. Bialle-
lic expression was also observed in the liver and brain
of 6-month-old lambs but not in their kidneys [22].
H19 DMD was paternally hypermethylated and mater-
nally hypomethylated in liver, muscle and kidney of all
three developmental stages independent of the com-
bined imprinting status of all IGF2 expressed transcripts.
This finding challenges the boundary model [12,13] pos-
tulating that the vertebrate eleven-zinc finger protein
CTCF binds the maternal unmethylated H19 DMD
insulating the upstream IGF2 promoters from enhancers
downstream of H19. On the paternal allele the methy-
lated DMD abolishes CTCF binding and enhancers 3’ of
H19 have access to IGF2 promoters. Our results demon-
strate that IGF2 is expressed from both alleles, mainly in
adult liver and, to a much lesser extent in skeletal mus-
cle and kidney, although H19 DMD is indeed differen-
tially methylated. Histone modifications might still cause
these effects but if so, they would be independent of
DNA methylation. Investigations of mouse Igf2 DMR 1
and 2 led to a model of parent-specific chromatin loops
that regulate Igf2 imprinting [14]. DNA methylation at
DMR 1 and 2 in our samples does not support a par-
ent-specific chromatin loop model regulating IGF2
imprinting in pig. It remains inconclusive if subtle dif-
ferences in DNA methylation in DMR1 between foetal
and adult liver and that between the parental alleles in
DMR2 of foetal and newborn liver are involved in the
control of the IGF2 imprinting status.
Conclusions
From our imprinting and DNA methylation analyses we
conclude, firstly, that IGF2 expression from both paren-
tal alleles in adult porcine liver and relaxation of IGF2
imprinting in adult porcine muscle are not associated
with DNA methylation variation at and around at least
one CTCF binding site in H19 DMD. Secondly, the
lower DNA methylation content in DMR1 in foetal
liver, as compared to adult liver, should be evaluated on
molecules from which the parental origin could be
established. Thirdly, similar to DMR1 porcine DMR2 is
hypermethylated on both parental alleles rather than dif-
ferentially methylated, as observed for H19 DMD.
Furthermore, the maternal DMR2 allele was more
methylated in foetal and newborn animals when com-
pared to the respective paternal allele. Finally, the transi-
tion of IGF2 imprinting in foetal liver to IGF2
expression from both alleles in adult liver may inherent
new mechanisms involved in IGF2 imprinting regulation
and provides a promising subject for further study.
Methods
Animals
From a collection of Swiss Large White pigs 2 male foe-
tus, 1 female and 1 male newborn and 6 adult boars
were selected based on their heterozygosity for the
microsatellite marker SWC9 located in the 3’-UTR of
the IGF2 gene.
DNA and RNA isolation and first strand cDNA synthesis
DNA was isolated from liver, skeletal muscle and kidney
tissues using the DNeasy Blood & Tissue Kit from Qia-
gen (Hombrechtikon, Switzerland). RNA extraction was
performed with Trizol® Reagent according to the manu-
facturer’s protocol (Invitrogen, Lucerne, Switzerland).
Total RNA was digested with RNase-Free DNAse I
according to the supplier’s instructions (Ambion, Rotk-
reuz, Switzerland). DNA free RNA was reverse tran-
scribed using a First-Strand cDNA Synthesis Kit (GE
Healthcare, Glattbrug, Zurich) and products were subse-
quently purified with QIAquick columns (Qiagen).
Imprinting status
Imprinting status was investigated by means of the
SWC9 microsatellite marker located in the 3’-UTR of
the IGF2 gene (Figure 1). The SWC9 microsatellite mar-
ker was amplified using Qiagen’s Multiplex PCR Master
Mix including a FAM labeled forward primer. PCR was
performed with an initial step at 94°C for 15 minutes
and 34 cycles of a denaturation step at 94°C for 30 sec-
onds, an annealing step at 60°C for 1 and a half minutes
and an elongation step at 72°C for 1 minute, and a final
elongation for 10 minutes. All samples including the
standard samples were analysed in triplicates and sub-
jected to the same PCR run in a 96 well plate.
Sequences of the PCR primers are shown in Supplemen-
tary Table 1. Following PCR 1 μl of each reaction was
combined with 10 μl of genotyping mix (980 μl of HiDi
formamide and 20 μl of GeneScanTM-500 LIZTM Size
Standard (Applied Biosystems, Rotkreuz, Switzerland).
The mixture was denatured for 2 min., chilled on ice
and loaded on an ABI 3730 capillary sequencer (Applied
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Biosystems). Data was analyzed using GeneMapper soft-
ware version 4.0 (Applied Biosystems). A standard dilu-
tion series was established based on the peak areas of
mixed DNA samples from two homozygous individuals
for the respective SWC9 236 and SWC9 247 alleles. We
used ratios of 32:1, 16:1, 8:1, 4:1, 2:1, 1:1, 1:2, 1:4, 1:8,
1:16, and 1:32 of the respective SWC9 236 and SWC9
247 homozygous DNA samples. The ratio of the peak
areas was used to calculate the ratio between the SWC9
alleles 236 and 247 according to the formula y =
0.9519x + 0.014 Figure 2 and[20].
Bisulfite sequencing
DNA was converted with the EpiTect Bisulfite kit
according to the supplier’s manual (Qiagen). Bisulfite-
conversion-based methylation PCR primers were
designed with the program Methprimer http://www.uro-
gene.org/methprimer/index.html and in the case of
IGF2_DMR2 with Methyl Primer Express (ABI). Primer
sequences and product sizes of the 4 fragments covering
the H19 DMD (H19_DMD_1, H19_DMD_2,
H19_DMD_3, H19_DMD_4), the IGF2 DMR1
(IGF2_DMR1) and the IGF2 DMR2 (IGF2_DMR2) is
shown in Additional file 1 Table S1. PCR was performed
with the Multiplex PCR Master Mix and products from
liver, skeletal muscle and kidney were cloned (TOPO
TA Cloning Kit (Invitrogen). White colonies were
picked diluted in 50 μl water and amplified with the
illustra™ TempliPhi amplification kit (GE Healthcare)
and sequenced on an ABI 3730 capillary sequencer
(Applied Biosystems). Bisulfite sequencing analysis was
performed with the programs BiQ Analyzer http://biq-
analyzer.bioinf.mpi-sb.mpg.de/ and MethTools http://
genome.fli-leibniz.de/methtools/.
DNA methylation analysis using methyl-sensitive
restriction endonuclease SacII and ‘hot-stop’ PCR
About 100 ng genomic DNA was digested over night
with the methyl-sensitive SacII endonuclease (New Eng-
land BioLabs, Allschwil, Switzerland). CpG methylation
of the recognition site CCGCGG inhibits digestion. A
SacII recognition site is present in a CTCF binding site
5’ upstream of H19 and is referred to pig repeat P2 [5].
We previously re-sequenced the pig imprinting control
region (ICR) containing the three pig CTCF binding
sites upstream of H19. By this means we identified two
SNPs, one at position AY044827.1:g.32530C>T and the
other at position AY044827.1:g.32619G>A. PCR primers
(’hot-stop’) were designed which encompass the CTCF
binding site in P2 and the two SNPs (Supplemented
Table 1). The forward primer is tailed with a M13 for-
ward sequence. An aliquot of the SacII digested DNA
was PCR amplified for each sample using these primers
by a ‘hot-stop’ PCR procedure for linear quantification
of allele ratios [23]. The ‘hot-stop’ PCR was performed
with Multiplex PCR Master Mix (Qiagen) for 35 cycles
with an initial denaturation step at 94°C for 15 min fol-
lowed by denaturation at 94°C for 30 sec, an annealing
temperature of 55°C for 30 sec, an annealing tempera-
ture of 68°C for 30 sec and an elongation step at 72°C
for 30 sec. The PCR was then paused after these 34
cycles at 72°C and 0.2 μM IRDye™700 labeled M13 pri-
mers was added to the reaction. The PCR was then
resumed for an additional cycle and a final elongation
step at 72°C for 10 min.
The PCR product contains a common 5’...CGCG...3’
recognition site for BstUI (New England BioLabs) and a
second that includes the AY044827.1:g.32530C>T SNP
which was used to discriminate the parental origin of
the alleles in this fragment of H19 DMD. An aliquot of
the ‘hot-stop’ PCR was subsequently digested over night
with BstUI according to the supplier’s recommendation.
The digested products were separated on a 1.5% agarose
gel and scanned on an Odyssey Infrared Imaging System
according to LI-COR’s instruction (LI-COR Biosciences,
Bad Homburg, Germany). Bands were visualized using
the LI-COR Odyssey software.
Parent of origin determination of alleles at the IGF2
DMR2
To determine the allele origin of IGF2 DMR2 we used a
single nucleotide polymorphism (SNPs) in the 3’-UTR at
position IGF2-exon9-612A>T. Based on this SNP we
analyzed parental DNA methylation patterns at the
IGF2 DMR2.
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